Serotonin receptors of type 6 (5-ht6): From neuroscience to clinical pharmacology

Current Medicinal Chemistry

Volumn 20, Issue 3, 2013, Pages 371-377

  Marazziti, Donatella ^a   Baroni, Stefano ^a   Borsini, Franco ^b   Picchetti, Michela ^a   Vatteroni, Elena ^a   Falaschi, Valentina ^a   Catena Dell'Osso, Mario ^a  

^a UNIVERSITY OF PISA   (Italy)

^b Sigma Tau SpA   (Italy)

Author keywords

Agonists; Antagonists; Clinical pharmacology; Distribution; Neurochemistry; Serotonin; Serotonin receptors; Serotonin receptors of type 6

Indexed keywords

2 ETHYL 5 METHOXY N,N DIMETHYLTRYPTAMINE; 4 AMINO N [2,6 BIS(METHYLAMINO) 4 PYRIDINYL]BENZENESULFONAMIDE; 4 AMINO N [2,6 BIS(METHYLAMINO) 4 PYRIMIDINYL]BENZENESULFONAMIDE; 5 CHLORO N [4 METHOXY 3 (1 PIPERAZINYL)PHENYL] 3 METHYL 2 BENZOTHIOPHENESULFONAMIDE; 5 METHOXY N,N DIMETHYLTRYPTAMINE; ANTIDEPRESSANT AGENT; BVT 5182; BVT 74316; CLOZAPINE; E 6801; LY 586713; N (3,5 DICHLORO 2 METHOXYPHENYL) 4 METHOXY 3 (1 PIPERAZINYL)BENZENESULFONAMIDE; NEUROLEPTIC AGENT; NOOTROPIC AGENT; PRX 07034; RO 65 7199; RO 66 0074; SB 258510; SB 258585; SB 357134; SB 699929; SEROTONIN 6 ANTAGONIST; SEROTONIN 6 RECEPTOR; ST 1936; SUVN 504; SUVN 594; UNCLASSIFIED DRUG; UNINDEXED DRUG; WAY 181187; WAY 208466; WAY 466;

BRAIN; BRAIN CORTEX; BRAIN ELECTROPHYSIOLOGY; CELL STRAIN HEK293; CLINICAL PHARMACOLOGY; CORPUS STRIATUM; FRONTAL CORTEX; HIPPOCAMPUS; HUMAN; IN VITRO STUDY; IN VIVO STUDY; NEUROCHEMISTRY; NEUROSCIENCE; NONHUMAN; OLFACTORY BULB; OLFACTORY CORTEX; PREFRONTAL CORTEX; REVIEW; SCHIZOPHRENIA; SPINAL GANGLION;

EID: 84877965446     PISSN: 09298673     EISSN: 1875533X     Source Type: Journal    
DOI: 10.2174/0929867311320030008     Document Type: Review

References (181)

1. Clark, L.; Roiser, J.P.; Cools, R.; Rubinsztein, D.C.; Sahakian, B.J.; Robbins, T.W. Stop signal response inhibition is not modulated by tryptophan depletion or the serotonin transporter polymorphism in healthy volunteers: implications for the5-HT theory of impulsivity. Psychopharmacology (Berl), 2005 Nov, 182(4), 570-8. Epub 2005 Oct 19. PubMed PMID: 16163530. (Pubitemid 41464639)
2. Nordquist, N.; Oreland, L. Serotonin, genetic variability, behaviour, and psychiatric disorders-A review. Ups. J. Med. Sci., 2010 Feb, 115(1), 2-10. Review. PubMed PMID: 20187845; PubMed Central PMCID: PMC2853349.
3. Stahl, S.M,; Essential neuropsychopharmacology -neuroscientific basis and pratical applications; Cambridge: Cambridge University Press, 2008.
4. Monsma, F.J.; Jr., Shen Y.; Ward, R.P.; Hamblin, M.W.; Sibley, D.R. Cloning and expression of a novel serotonin receptor with affinity for tricyclic psychotropic drugs. Mol. Pharmacol., 1993, 43, 320-327 (Pubitemid 23081986)
5. Roth, B.L.; Craigo, S.C.; Choudhary, M.S.; Uluier, A.; Monsma, F.J. Jr.; Shen, Y.; Meltzer, H.Y.; Sibley, D.R. Binding to typical and atypical antipsychotic agents to 5-hydroxytryptamine-6 and 5-hydroxytryptamine-7 receptors. J. Pharmacol. Exp. Ther., 1994 268, 1403-1410 (Pubitemid 24100360)
6. Kohen, R.; Metcalf, M.A.; Khan, N.; Druck, T.; Huebner, K.; Lachwicz, J,E.; Meltzer, H.Y.; Sibley, D.R.; Roth, B.L.; Hamblin, M.W. Cloning, characterization, and chromosomal localization of a human 5-HT6 serotonin receptor. J. Neurochem., 1996, 66, 47-56 (Pubitemid 26010763)
7. Riemer, C.; Borroni, E.; Levet-Trafit, B.; Martin, J.R.; Poli, S.; Porter, R.H.P.; Bos, M. Influence of the 5-HT6 receptor on acetylcholine release in the cortex: pharmacological characterization of 4-(2-bromo-6-pyrrolidin-1- ylpyridine-4-sulfonyl)phenylamine, a potent and selective 5-HT6 receptor antagonist. J. Med. Chem., 2003, 46, 1273-1276 (Pubitemid 36428233)
8. Branchek, T.A.; Blackburn, T.P. 5-HT6 receptors as emerging targets for drug discovery. Ann. Rev. Pharmacol., 2000, 40, 319-334 (Pubitemid 30340685)
9. Geldenhuys, W.J.; Van der Schyl, C.J. Serotonin 5-HT6 receptor antagonists for the treatment of Alzheimer's disease. Curr. Topics in Med. Chem., 2008, 8, 1035-1048
10. Geldenhuys, W.J.; Van der Schyl, C.J. The serotonin 5-HT6 receptor: a viable drug target for treating cognitive deficits in Alzheimer's disease. Expert. Rev. Neurother., 2009, 9, 1073-1085
11. Johnson, C.N.; Ahmed, M.; Miller, N.D. 5-HT6 receptor antagonists: prospective for the treatment of cognitive disorders including dementia. Curr. Op. Drug. Dis. Dev., 2008, 11, 642-654
12. Maher-Edwards, G.; Zvartau-Hind, M.; Hunter, A.J.; Gold, M.; Hopton, G.; Jacobs, G.; Davy, M.; Williams, P. (2009) Double-Blind, Controlled Phase II Study of a 5-HT6 Receptor Antagonist, SB-742457. Curr. Alzheimer. Res., 2009, Dec 31. [Epub ahead of print]
13. Rossé, G.; Schaffhauser, H. 5-HT6 receptor antagonists as potential therapeutics for cognitive impairment. Curr. Topics Med. Chem., 2010, 10, 207-221
14. Upton, N.; Chuang, T.T.; Hunter, A.J.; Virley, D.J. 5-HT6 receptor antagonists as novel cognitive enhancing agents for Alzheimer's disease. Neurotherapeutics, 2008, 5, 458-469 (Pubitemid 351952494)
15. Witty, D.; Ahmed, M.; Chuang, T-T. Advances in the design of 5-HT6 receptor ligands with therapeutical potential. Progress. Med. Chem., 2009, 48, 163-225
16. Heal, D.J.; Smith, S.L.; Fisas, A.; Codony, X.; Buschmann, H. Selective 5-HT6 receptor ligands: progress in the development of a novel pharmacological approach to the treatment of obesity and related metabolic disorders. Pharmacol. Ther., 2008, 117, 207-231.
17. Marazziti, D.; Baroni, S.; Catena-Dell'Osso, M.; Bordi, F.; Borsini, F. Serotonin receptors of type 6 (5-HT6): what can we expect from them? Curr Med Chem. 2011, 18(18):2783-2790.
18. MacDermont, J.; Higashida, H.; Wilson, S.P.; Matsuzawa, H.; Minna, J.; Nirenberg, M. Adenylate cyclase and acetylcholine release regulated by separate serotonin receptors of somatic cell hybrids. Proc. Natl. Acad. Sci. USA, 1979, 76, 1135-1139 (Pubitemid 9135168)
19. Berry-Kravis, E.; Dawson, G. Characterization of an adenylate cyclaselinked serotonin (5-HT1) receptor in a neuroblastoma x brain explant hybrid cell line (NCB-20). J. Neurochem., 1983, 40, 977-985 (Pubitemid 13163324)
20. Conner, D.A.; Mansour, T.E. Serotonin receptor-mediated activation of adenylate cyclase in the neuroblastoma NCB.20: a novel 5-hydroxytryptamine receptor. Mol. Pharmacol., 1990, 37, 742-751 (Pubitemid 20171511)
21. Cossery, J.M.; Mienville, J-M.; Sheehy, P.A.; Mellow, A.M.; Chuang, D-M. Characterization of two distinct 5-HT receptors coupled to adenylate cyclase activation and ion current generation in NCB-20 cells. Neurosci. Lett., 1990, 108, 149-154 (Pubitemid 20036447)
22. Usworth, C.D.; Molinoff, P.B. Characterization of a 5-hyroxytyptamine receptor in mouse neuroblastoma N18TG2 cells. J. Pharmacol. Exp. Ther., 1994, 269, 245-255
23. Ruat, M.; Traiffort, E.; Arrang , J-M.; Tardivel-Lacombe, J.; Diaz, J.; Leurs, R.; Schwartz, J-C. A novel rat serotonin (5-HT6) receptor: molecular cloning, localization and stimulation of cAMP. Biochem. Biophy. Res. Comm., 1993, 193, 268-276 (Pubitemid 23199942)
24. Kohen, R.; Fashingbauer, L.A.; Heidman, D.E.A.; Guthrie, C.R.; Hamblin, M.W. Cloning of the mouse 5-HT6 serotonin receptor and mutagenesis studies of the third cytoplasmatic loop. Mol. Brain Res., 2000, 90, 110-117 (Pubitemid 32537632)
25. Boess, F.G.; Monsma ,F.J. Jr.; Carolo, C.; Meyer, V.; Rudler, A.; Zwingelstein, C.; Sleight, A.J. Functional and radioligand binding characterization of rat 5-HT6 receptors stably expressed in HEK293 cells. Neuropharmacol., 1997, 36, 713-720 (Pubitemid 27272118)
26. Grimaldi, B.; Bonnin, A.; Fillion, M-P.; Ruat. M.; Traiffort, E.; Fillion, G. Charatcterization of 5-HT6 receptor and expression of 5-HT6 mRNA in the rat brain during ontogenetic development. Naunyn-Schmiedeberg's Arch. Pharmacol., 1998, 357, 393-400 (Pubitemid 28188316)
27. Hirst ,W.D.; Abrahamsen, B.; Blaney, F.E.; Calver, A.R.; Aloj, L.; Price, G.W.; Medhurst, A.D. Differences in the central nervous system distribution and pharmacology of the mouse 5-hydroxytryptamine-6 receptor compared with rat and human receptors investigated by radioligand binding, sitedirected mutagenesis, and molecular modelling. Mol. Pharmacol, 2003, 64, 1295-1308 (Pubitemid 37532219)
28. Setola, V.; Roth, B.L. Why mice are neither miniature humans nor small rats: a cautionary tale involving 5-hydroxytryptamine-6 serotonin receptor species variants. Mol. Pharmacol., 2003, 64, 1277-1278 (Pubitemid 37532216)
29. Bonasera, S.J.; Chu, H-M.; Brennan, T.J.; Tecott, L.H. A null mutation of the serotonin 6 receptor alters acute responses to ethanol. Neuropsychopharmacology, 2006, 31, 1801-1813 (Pubitemid 44106712)
30. Bibancos, T.; Jardim, D.L.; Aneas, I.; Chiavegatto, S. Social isolation and expression of serotonergic neurotransmission-related genes in several brain areas of male mice. Genes Brain Behav., 2007, 6, 529-539 (Pubitemid 47246219)
31. Olsen, M.A.; Nawoschik, S.P.; Schurman, B.R.; Schmitt, H.L.; Burno, M.; Smith, D.L.; Schechter, L.E. Identification of a human 5-HT6 receptor variant produced by alternative splicing. Brain Res. Mol. Brain Res., 1999, 64, 255-263 (Pubitemid 29052476)
32. Gerard, C.; El Mestkawy, S.; Lebrand, C.; Adrien, J.; Ruat, M.; Traiffort, E.; Hamon, M.; Martres, M-P. Quantitative RT-PCR distribution of serotonin 5-HT6 receptor mRNA in the central nervous system of control or 5,7-dihydroxytryptramine-trated rats. Synapse, 1996, 23, 164-173 (Pubitemid 26230563)
33. Ward, R.P.; Hamblin, M.W.; Lachowicz, J.E.; Hoffman, B.J.; Sibley, D.R.; Dorsa, D.M. Localization of serotonin subtype 6 receptor messenger RNA in the rat brain by in situ hybridization histochemistry. Neurosci., 1995, 64, 1105-1111
34. Ward R, Dorsa DM (1996) Colocalization of serotonin receptor subtypes 5-HT2A, 5-HT2C, and 5-HT6 with neuropeptides in rat striatum. J Comp Neurol 370: 405-414 (Pubitemid 26235237)
35. Stefuly, J.; Jerney, B.; Civin-Sain, L.; Rinner, I.; Schauenstein, K. mRNA expression of serotonin receptors in cells of the immune tissues of the rat. Brain Behav. Imm., 2000, 14, 219-224 (Pubitemid 32280876)
36. Gerard, C.; Martres, M-P.; Lefevre, K.; Miquel, M-C.; Vergé, D.; Lanfumey, L.; Doucet, E.; Hamon ,M.; El Mestkawy, S. Immuno-localization of serotonin in 5-HT6 receptor-like material in the rat central nervous system. Brain Res., 1997, 746, 207-219 (Pubitemid 27060349)
37. Hamon, M.; Doucet, E.; Lefevre, K.; Miquel, M-C.; Lanfumey, L.; Insausti, R.; Frechilla, D.; Del Rio, J.; Vergé, D. Antibodies and antisense oligonucleotide for probing the distribution and putative functions of central 5-HT6 receptors. Neuropsychopharmacol., 1999, 21, 68S-76S (Pubitemid 29396473)
38. Hirst, W.D.; Minton, J.A.L.; Bromidge, S.M.; Moss, S.F.; Latter, A.J.; Riley, G.; Routledge, C.; Middlemiss, D.N.; Price, G.W. Characterization of [125I]-SB-258585 binding to human recombinant and native 5-HT6 receptors in rat, pig, and human brain tissue. Brit. J. Pharmacol., 2000, 130, 1597-1605 (Pubitemid 30611937)
39. Roberts, J.C.; Reavill, C.; East, S.Z.; Harrison, P.J.; Patel, S.; Routledge, C.; Leslie, R.A. The distribution of 5-HT6 receptors in rat brain: an autoradiographic binding study using the radiolabelled 5-HT6 receptor antagonist [125I] SB-258585. Brain Res. 2002 934 49-57 (Pubitemid 34286567)
40. Yoshioka, M.; Matsumoto, M.; Togashi, H.; Mori, K.; Saito, H. Central distribution and function of 5-HT6 receptor subtype in the rat brain. Life Sci., 1998, 62, 1473-1471
41. Wooley, ML.; Marsden, C.A.; Fone, K.C.F. 5-HT6 receptors. Curr. Drug Targets, 2004, 3, 59-89
42. Bonsi, P.; Cuomo, D.; Ding, J.; Sciamann, G.; Ulrich, S.; Tscherter, A.; Bernardi, G.; Surmeier, D.J.; Pisani, A. Endogenous serotonin excites striatal cholinergic interneurons via the activation of 5-HT2C, 5-HT6, and 5-HT7 serotonin receptors: implications for extrapyramidal side effects of serotonin reuptake inhibitors. Neuropsychopharmacol ., 2007, 32, 1840-1854 (Pubitemid 47076377)
43. Riccio, O.; Potter, G.; Walzer, C.; Vallet, P.; Szabo, G.; Vutskits, L.; Kiss, J.Z.; Dayer, A.G. Excess of serotonin affects embryonic interneuron migration through activation of the serotonin receptor 6. Mol. Psychiatr., 2009, 14, 280-290
44. Jackson, Z.E.; Stringer, B.M.J.; Foster, G.A. Identification of 5-HT receptor subtypes in a homogeneous population of presumptive serotonergic neurones. Neuropharmacology, 1997, 36, 543-548 (Pubitemid 27272099)
45. Marazziti, D.; Baroni, S.; Pirone, A.; Giannaccini, G.; Betti, L.; Schmid, L.; Vatteroni, E.; Palego, L.; Borsini, F.; Bordi, F.; Piano, I.; Gargini, C.; Castagna, M.; Catena-Dell'Osso, M.; Lucacchini, A. Distribution of serotonin receptor of type 6 (5-HT6) in human brain post-mortem. A pharmacology, autoradiography and immunohistochemistry study. Neurochem Res., 2012 37(5):920-927
46. Marazziti, D.; Baroni, S.; Pirone, A.; Giannaccini, G.; Betti, L.; Testa, G.; Schmid, L.; Vatteroni, E.; Palego, L.; Borsini, F.; Bordi, F.; Piano, I.; Gargini, C.; Castagna, M.;. Lucacchini, A.; Catena-Dell'Osso, M. Cellular localization of serotonin receptor of type 6 (5-HT6) in human prefrontal cortex and hippocampus: A immunohistochemical and immufluorescence study. Neurochem. Int. (in press).
47. Marcos, B.; Cabero, M.; Solas, M.; Aisa, B.; Ramirez, M.J Signalling path ways associated with 5-HT6 receptors: relevance for cognitive effects. Int. J. Neuropsychopharmacol., 2009, Sep 9, 1-10. [Epub ahead of print]
48. Schechter, L.E.; Lin. Q.; Smith, D.L.; Zhang, G.; San, Q.; Polatt, B.; Brandt, M,R.; Dawson, L.A.; Cole, D.; Bernotas, R.; Ribichaud, A.; Rosenweig-Lipson, S.; Beyer, C.E. Neuropharmacological profile of novel and selective 5-HT6 receptor agonists: WAY-181187 and WAY-208466. Neuropsychopharmacol., 2008, 33, 1323-1335 (Pubitemid 351521711)
49. Marcos, B.; Aisa, B.; Ramirez, M.J. Functional interaction between 5-HT6 receptors and hypothalamic-pituitary-Adrenal axis: cognitive implications. Neuropharmacology, 2008a, 54, 708-714
50. Marcos, B.; Gil-Bea, F.J.; Hirst, W.D.; Garcia-Alloza, M.; Ramirez, M.J. Lack of localization of 5-HT6 receptors on cholinergic neurons: implication of multiple neurotransmitter systems on 5-HT6 receptor-mediated acetylcholine release. Eur. J. Neurosci., 2006, 24, 1299-1306 (Pubitemid 44401652)
51. West, P.J.; Marcy, V.R.; Marino, M.J.; Schaffhauser, H. Activation of the 5-HT6 receptor attenuates long-term potentation and facilitates GABAergic neurotransmission in rat hippocampus. Neuroscience, 2009, 164, 692-701
52. Lacroix, L.P.; Dawson, L.A.; Hagan, J.J.; Heidbreder, C.A. 5-HT6 receptor antagonist SB-271046 enhances extracellular levels of monoamines in the rat medial prefrontal cortex. Synapse, 2004, 51, 158-164 (Pubitemid 38018798)
53. Dawson, L.A.; Nguyen, H.Q.; Li, P. In vivo effects of the 5-HT6 antagonist SB-271046 on striatal and frontal cortex extracellular concentrations of noradrenaline, dopamine, 5-HT, glutamate and aspartate. Brit. J. Pharmacol., 2000, 130, 23-26 (Pubitemid 30248421)
54. Dawson, L.A.; Nguyen, H.Q.; Li, P. The 5-HT6 receptor antagonist SB-271046 selectively enhances excitatory neurotransmission in the rat frontal cortex and hippocampus. Neuropsychopharmacol., 2001, 25, 662-66
55. Frantz, K.J.; Hansson, K.J.; Stouffer, D.G.; Parson, L.H. 5-HT6 receptor antagonism potentiates the behavioural and neurochemical effects of amphetamine but not cocaine. Neuropharmacology, 2002, 42, 170-180 (Pubitemid 34137020)
56. Doleviczeny, Z.; Vizi, E.S.; Gacsalyi, I.; Pallagi, K.; Volk, B.; Harsing, L.G. Jr.; Halmois, G.; Lendvai, B.; Zelles, T. 5-HT6/7 receptor antagonists facilitate dopamine release in the cochlea via GABAergic disinhibitory mechanism. Neurochem. Res., 2008, 33, 2364-2372
57. Valentini, V.; De Luca, M.A.; Borsini, F.; Frau, R.; Di Chiara, G. Behavioral and biochemical characterization of ST1936, a new 5-HT6 agonist. Behav. Pharmacol., 2009, 20, S36
58. Minabe, Y.; Shirayama, Y.; Hashimoto, K.; Routledge, C.; Hagan, J.J.; Ashny, C.R. Jr. Effect of acute and chronic administration of the selective 5-HT6 receptor antagonist SB-271046 on the activity of midbrain dopamine neurons in rats: an in vivo electrophysiological study. Synapse , 2004, 52, 20-28 (Pubitemid 38316267)
59. Boess, FG.; Monsma, F.J. Jr.; Sleight, A.J. Identification of residues in transmembrane regions III and VI that contribute to the ligand binding site of the serotonin 5-HT6 receptor. J Neurochem., 1998, 71, 2169-2177 (Pubitemid 28491575)
60. Bromidge, S.M.; Griffith, K.; Heightman, T.D.; Jenniung, A.; King, F.D.; Moss, S.F.; Newman, H.; Riley, G.; Routledge, C.; Sarafinowska, H.T.; Thomas, D.R. Novel (4-piperazin-1-ylquinolin-6-yl) arylsulfonamides with high affinity and selectivity for the 5-HT6 receptor. Bioorg. Med. Chem. Lett., 2001b, 11, 2843-2846
61. Kang ,H.; Lee, W.K.; Choi, Y.H.; Vukuti, K.M.; Bang, W.G.; Yu, Y.G. Molecular analysis of the interaction between the intracellular loops of the human serotonin receptor type 6 (5-HT6) and the subunit of GS protein. Biochem. Biophysic. Res. Commun., 2005, 329, 684-692 (Pubitemid 40311798)
62. Romero, G.; Sanchez, E.; Pujol, M.; Perez, P.; Codony, X.; Holenz, J.; Buschmann, H.; Pauwels, P.J. Efficacy of selective 5-HT6 receptor ligands determined by monitoring 5-HT6 receptor-mediated cAMP signaling pathways. Br. J. Pharmacol., 2006, 148, 1133-1143. (Pubitemid 44223019)
63. Schoeffter, P.; Waeber, C. 5-hydroxytryptamine receptors with a 5-HT6 receptor-like profile stimulating adenylyl cyclase activity in pig caudate membranes. Naunyn-Schmiedeberg's Arch. Pharmacol., 1994, 350, 356-360
64. Yun, H-M.; Baik, J-H.; Kang, I-S.; Jin, C.; Rhim, H. Physical interactions of JAB1 with human serotonin 6 G-protein coupled receptor and their possible role in cell survival. J. Biol. Chem., 2010, 285, 10016-10029
65. Alcade, E.; Mesquida, N.; Frigola, J.; Lopez-Perez, S.; Mercé, R. Indenebased scaffolds. Design and syntheis of novel serotonin 5-HT6 receptor ligands. Org. Biomol. Chem., 2008, 6, 3795-3810
66. Alcade, E.; Mesquida, N.; Frigola, J.; Lopez-Perez, S.; Mercé, R. Indenebased scaffolds. 2. An indole-indene switch: discovery of novel indenylsulphonamides as 5-HT6 serotonin receptor agonists. J. Med. Chem., 2009a, 52, 675-687
67. Baker, L.P.; Nielsen, D.M.; Impey, S.; Metcalf, M.A.; Poser, S.W.; Chan, G.; Obrietan, K.; Hamblin, M.W.; Storm, D.R. Stimulation of Type 1 and Type 8 Ca2+/Calmodulin-sensitive Adenylyl Cyclases by the Gs-coupled 5-Hydroxytryptamine Subtype 5-HT7A Receptor. J. Biol. Chem., 1998, 273, 17469-17476 (Pubitemid 28355078)
68. Dupuis. D.S.; Mannoury la Cour, C.; Chaput, C.; Verriele, L.; Lavielle, G.; Millan, M.J. Actions of novel antagonists and antipsychotic agents at recombinant rat 5-HT6 receptors: a comparative study of coupling to GS. Eur. J. Pharmacol., 2008, 588, 170-177
69. Bymaster, F.P.; Falcone, J.F.; Bauzon, D.; Kennedy, J.S.; Schenk. K.; De-Lapp, N.W.; Cohen, M.L. Potent antagonism of 5-HT3 and 5-HT6 receptors by olanzapine. Eur. J. Pharmacol., 2001, 430, 341-349 (Pubitemid 33050060)
70. Yun, H-M.; Kim, S.; Kim, H-J.; Kostenis, E.; Kim, J. II.; Seong, J.Y.; Baik, J-H.; Rhim, Y. The novel cellular mechanism of human 5-HT6 receptor through an interaction with Fyn. J. Biol. Chem., 2007, 282, 5496-5505 (Pubitemid 47093777)
71. Purohit, A.; Harrick-Davis, K.; Teitler, M. Creation, expression, and characterization of a constitutively active mutant of the human serotonin 5-HT6 receptor. Synapse, 2003, 47, 218-224 (Pubitemid 36056835)
72. Sebben, M.; Ansanay, H.; Bockaert, J.; Dumuis, A. 5-HT6 receptors positively coupled to adenylyl cyclase in striatal neurons in culture. NeuroRep. 1994, 5, 2553-2557
73. Sleight, A.J.; Boess, F.G.; Bos, M.; Levet-Trafit, B.; Riemer, C.; Bourson, A. Characterization of Ro 04-6790 and Ro 63-0563: potent and selective antagonists at human and rat 5-HT6 receptors. Brit. J. Pharmacol., 1998, 1245, 556-562 (Pubitemid 28254513)
74. Bos, M.; Sleight, A.J.; Godel, T.; Martin, J.R.; Riemer, C.; Stadler, H. 5-HT6 receptor antagonists: lead optimisation and biological evaluation of N-Aryl and N-heteroaryl 4-Amino-benzene sulfonamides. Eur. J. Med. Chem., 2001, 36, 165-178 (Pubitemid 32304518)
75. Ahmed, M.; Briggs, M.A.; Bromidge, S.M.; Buck ,T.; Campbell, L.; Deeks, N.J.;, Garner, A.; Gordoni, L.; Hamprecht, D.W.; Holland, V.; Johnson, C.N.; Medhurst, A.D.; Mitchell, D.J.; Moss, S.F.; Powles, J.;, Seal, J.T.;, Stean, T.O.; Stemp, G.; Thompson, M.; Trail, B.; Upton, N.; Winborn, K.; Witty, D.R. Bicyclic heteroarylpiperazine as selective brain penetrant 5-HT6 receptor antagonists. Bioorg. Med. Chem. Lett., 2005, 15, 4867-71 (Pubitemid 41354824)
76. Trani ,G.; Baddeley, S.M.; Briggs, M.A.; Chuang, T.T.; Deeks, N.J.; Johnson, C.N.; Khazragi, A.A.; Mead, T.L.; Medhurst, A.D.; Milner, P.H.; Quinn, L.P.; Ray, A.M.; Rivers, D.A.; Stean, T.O.; Stemp, G.; Trail, B.K.; Witty, D.R. Tricyclic azepine derivatives as selective brain penetrant 5-HT6 receptor antagonists. Bioorg. Med. Chem. Lett., 2008, 18, 5698-5700
77. Bromidge, S.M.; Clarke, S.E.; Gager, T.; Griffith, K.; Jeffrey, P.; Jenning, A.J.; Joiner, G.F.; King, F.D.; Lovell, P.J.; Moss, S.F.; Newman, H.; Riley, G.; Rogers, D.; Routledge, C.; Serafinowska, H.; Smith, D.R. Phenyl benzensulfonamides are novel and selective 5-HT6 antagonists: identification of N(2,5-dibromo-3-fluorophenyl)-4-methoxy-3-pioperqzin-A-ylbenzensulfonamide (SB357134). Bioorg. Med. Chem. Lett., 2001a, 11, 55-58 (Pubitemid 32006123)
78. Wesolowska, A.; Nikiforuk, A. Effects of the brain-penetrant and selective 5-HT6 receptor antagonists SB-3999885 in animal models of anxiety and depression. Neuropharmacology, 2007, 52, 1274-1283 (Pubitemid 46527703)
79. Bromidge, S.M.; Brown, A.M.; Clarke, S.E.; Dodgson, K.; Gagewr, T.; Grassam, H.L.; Jeffrey, P.M.; Joiner, G.F.; King, F.D.; Middlemiss, D.N.; Moss, S.F.; Newman, H.; Riley, G.; Routledge, C.; Wyman, P. 5-choro-N-(4-methoxy-3- piperazin-1-yl-phenyl)-3-methyl-2-benzothiophenesulfonamide (SB271046): a potent selective, and orally bioavailable 5-HT6 receptor antagonist. J. Med. Chem., 1999, 42, 202-205 (Pubitemid 29069853)
80. King, MV.; Fone, K.C.F.; Shacham, S.; Gannon, K.S. The novel 5-HT6 antagonist, PRX-07034, enhances memory and reduces food intake in a neurodevelopmental model of schizophrenia. J. Psychopharmacol., 2007, 21, A57
81. Hughert, A.; Brisander, M.; Wrange, U.; Kritikos, M.; Norrlind, B.; Svensson, M.; Bisrat, M, Physical characterization of anhydrous and hydrous forms of the hydrochloride salt of BVT.5182 a novel 5-HT6 receptor antagonist. Drug Dev. Ind. Pharmacy., 2006, 32, 185-196
82. Suter, L.; Haiker, M.; de Vera, M.C.; Albertini, S. Effect of two receptor antagonists on rat liver: a molecular approach. Pharmacogenomics J., 2003, 3, 320-334 (Pubitemid 38072170)
83. Glennon, R.A.; Lee, M.; Rangisetty, J.B.; Dukat, M.; Roth, B.L.; Savage, J.E.; McBride, A.; Rauser, L.; Hufeisen, S.; Lee, D.K. 2-Substituted tryptamine: agents with selectivity for 5-HT6 serotonin receptors. J. Med. Chem., 2000, 43, 1011-1018 (Pubitemid 30152305)
84. Schechter, L.E.; Smith, D.L.; Li, P.; Lin, Q.; Rosenweig-Lipson, S.; Robichaud, A.; Bernotas, R.; Beyer, C.E. WAY-466: pharmacological profile of a novel and selective 5-HT6 receptor agonist. Soc. Neurosci Meeting, 2004, 394.11
85. Cole, D.C.; Stock, J.R.; Lennox, W.J.; Bernotas, R.C.; Ellingboe, J.W.; Boikess, S.; Coupet, J.; Smith, D.L.; Leung, L.; Zhang, G-M.; Feng, X.; Kelly, M.F.; Galante, R.; Huang, P.; Dawson, L.A.; Marquis, K.; Rosenweig-Lipson, S.; Beyer, C.E.; Schechter, L.E. Discovery of N1-(6-chloroimidazo[2,1-b][1,3] thiazole-5-sulfoyl)tryptamine as a potent, selective, and orally active 5-HT6 receptor agonist. J. Med. Chem., 2007, 50, 5535-5538 (Pubitemid 350106003)
86. Cole, D.C.; Lennox, W.J.; Lombardi, S.; Ellingboe, J.W.; Bernotas, R.C.; Tawa, G.J.; Mazandarani, H.; Smith, D.L.; Zhang, G.; Coupet, J.; Schechter, L.E. Discovery of 5-Arylsulfonamido-3-(oyrrolidin-2-ymethyl)-1H-indole derivatives as potent, selective 5-HT6 receptor agonists and antagonists. J. Med. Chem., 2005, 48, 353-356 (Pubitemid 40139779)
87. Borsini, F.; Stasi, M.A.; Minetti, P.; Riccioni, T.; Mennini, T. Effect of ST1936, a 5HT6 ligand, on rodent adenylate cyclase and forced swimming test. Int. J. Neuropsychopharmacol., 2008, 11 (Suppl. 1), 123-124
88. Alcade, E.; Mesquida, N.; Lopez-Perez, S.; Frigola, J.; Mercé, J.; Holenz, J.; Pujol, M.; Hernandez , E. Indene-based frameworks targeting the 5-HT6 serotonin receptor: ring constrain in indenylsulfonamides using cyclic amines and structurally abbreviated counterparts. Bioorg. Med. Chem., 2009b, 17, 7387-7397
89. Isaac, M.; Slassi, A.; Xin, T.; MacLean, N.; Wilson, J, .; McCallum, K.; Wang, H.; Demchyshyn, 6-bicyclopiperazinyl-1-Arylsulphonylindoles derivatives as novel, potent, and selective 5-HT6 receptor antagonists. Bioorg. Med. Chem. Lett., 2000, 10, 1719-1721 (Pubitemid 30495247)
90. Tsai, Y.; Dukat, M.; Slassi, A.; MacLean, N.; Demchyshyn, L.; Savage, J.E.; Roth, B.L.; Hufesein, S.; Lee, M.; Glennon, R.A. N1-benzenesulfonyl) tryptamines as novel 5-HT6 antagonists. Bioorg. Med. Chem. Lett., 2000, 10, 2295-2299
91. Russell, M.G.N.; Baker, R.J.; Barden, L.; Beer, M.S.; Bristiw, L.; Broughton, H.B.; Knowles, M.; McAllister, G.; Patel, S.; Castro, J.L. NAryulsulfonylindole derivatives as serotonin 5-HT6 receptor ligands. J. Med. Chem., 2001, 44, 3881-3895 (Pubitemid 33051478)
92. Glennon, R.A. Higher-end serotonin receptors: 5-HT5, 5-HT6 , and 5-HT7. J. Med. Chem., 2003, 46, 2795-2812
93. Holenz, J.; Mercé, R.; Diaz, J.L.; Guitar, X.; Codony, X.; Dordal, A.; Romero, G.; Torrenz, A.; Mas, J.; Andaluz, B.; Hernandez, S.; Monroy, X.; Sanchez, E.; Nernandez, E.; Perez, R.; Cubi, R.; Sanfeliu, O.; Bushmann, H. Medicinal chemistry driven approaches toward novel and selective serotonin 5-HT6 receptor ligands. J. Med. Chem., 2005, 48, 1781-1795 (Pubitemid 40396311)
94. Mattsson, C.; Sonesson, C.; Sandahl, A.; Greiner, H.E.; Gassen, M.; Plaschke, J.; Leibrock, J.; Bottcher, H. 2-Alkyl-3-(1,2,3,6-tetrahydropyridin-4- yl)-1H-indoles as novel 5-HT6 receptor agonists. Bioorg. Med. Chem. Lett., 2005, 15, 4230-4234 (Pubitemid 41187992)
95. Zhou, P.; Yan, Y.; Bernotas, R.; Harrison, B.L.; Huryn, D.; Robichaud, A.J.; Zhan, G.M.; Smith, D.L.; Schechter, L.E. 4-(2-Aminoethoxy)-N- (phenylsulphonyl)indoles as novel 5-HT6 receptor ligands. Bioorg. Med. Chem. Lett., 2005, 15, 1393-1396 (Pubitemid 40268999)
96. Holenz, J.; Pauwels, P.; Diaz, J.L.; Mercé, R.; Codony, X.; Buschmann, H. medicinal chemistry strategies to 5-HT6 receptor ligands as potential cognitive enhancers and antiobesity agents. Drug Dis. Today, 2006, 11, 283-299
97. Sikazwe, D.; Bondarev, M.L.; Dukat, M.; Rangisetty, J.B.; Roth, B.L.; Glennon, R.A. Binding of sulphonyl-containing arylalkylamines at human 5-HT6 serotonin receptors. J. Med. Chem., 2006, 49, 5217-5225 (Pubitemid 44260217)
98. Kambhampati, R.; Konda, J.; Reballi, V.; Shinde, A.K.; Dubey, P.K.; Nirogi, R.V.S. Design, synthesis and preliminary screening of novel 3-(2-N,Ndimethylaminoethylthio) indole derivatives as potential 5-HT6 receptor ligands. J. Enz. Inhib. Med. Chem., 2008, 23, 302-312 (Pubitemid 351935048)
99. Dukat, M.; Mosier, P.D.; Kolanos, R.; Roth, B.L.; Glennon, R.A. Binding of serotonin and N1-benzenesulfonyltryptamine-related analogs at human 5-HT6 serotonin receptors: receptor modelling studies. J. Med. Chem., 2008, 51, 603-611 (Pubitemid 351252288)
100. Kim, H-J.; Doddreddy, M.R.; Choo, H.; Chy, Y.S.; No, K.T.; Park, W-K.; Pae, A.N. New serotonin 5-HT6 ligands from common feature pharmacophore hypotheses. J. Chem. Inf. Model., 2008a, 48, 197-206 (Pubitemid 351271065)
101. Kim, H-J.; Yun, H-M.; Kim, T.; Nam, G.; Roh, E.J.; Kistenis, E.; Choo, HY. P.; Paee, A,N.; Rhim, H. Functional human 5-HT6 receptor assay for high throughput screening of chemical ligands and binding proteins. Comb. Chem. HTS., 2008b, 11, 316-324 (Pubitemid 351705494)
102. Seong, C.M.; Park, W.Y.; Park, C.M.; Kong, J.Y.; Park, N.S. Discovery of 3-Aryl-3-methyl-1H-quinoline-2,4-diones as a new class of selective 5-HT6 receptor antagonists. Bioorg. Med. Chem. Lett., 2008, 18, 738-743
103. Alex, K.; Schwartz, N.; Khedkar, V.; Ali Sayyed, I.; Tillack, A.; Michalik, D.; Holenz, J.; Diaz, J.L.; Beller, M. Synthesis of 3-(2-N,Ndiethylaminoethoxy) indoles as potential 5-HT6 receptor ligands. Org. Biomol. Chem., 2008, 6, 1802-1807 (Pubitemid 351630368)
104. Liu, K.G.; Lo, J.R.; Comery, T.A.; Zhang, G.M.; Zhang, J.Y.; Kowal, D.M.; Smith, D.L.; Di, L.; Kerns, E.H.; Schechter, L.E.; Robichaud, A.J. A regionspecific syntheis of a series of 1-sulfonyl azepinoindoles as potent 5-HT6 ligands. Bioorg. Med. Chem., 2008, 18, 3929-3931
105. Liu, K.G.; Lo, J.R.; Comery, T.A.; Zhang, G.M.; Zhang, J.Y.; Kowal, D.M.; Smith, D.L.; Di, L.; Kerns, E.H.; Schechter, L.E.; Robichaud, A.J. Identification of a series of benzoxazoles as potent 5-HT6 ligands. Bioorg. Med. Chem., 2009a, 18, 1115-1117
106. Liu, K.G.; Lo, J.R.; Comery, T.A.; Zhang, G.M.; Zhang, J.Y.; Kowal, D.M.; Smith, D.L.; Di, L.; Kerns, E.H.; Schechter, L.E.; Robichaud, A.J. 1-Sulfonylindazoles as potent and selective 5-HT6 ligands. Bioorg. Med. Chem., 2009b, 19, 2413-2415
107. Liu, K.G.; Lo, J.R.; Comery, T.A.; Zhang, G.M.; Zhang, J.Y.; Kowal, D.M.; Smith, D.L.; Di, L.; Kerns, E.H.; Schechter, L.E.; Robichaud, A.J. Identification of a novel series of 3-piperidinyl-5-sulfonylindazoels as potent 5-HT6 ligands. Bioorg. Med. Chem., 2009c, 19, 3214-3216
108. Ivachtchencho, A.V.; Frolov, E.B.; Mitkin, O.D.; Kysil, V.M.; Khvat, A.V.; Okun, I.M.; Tkachenko, S.E. Synthesis and biological evaluation of novel -carboline analogues of dimebon as potent 5-HT6 receptor antagonists. Bioorg. Med. Chem. Lett., 2009, 19, 3183-3187
109. Dawson, A.L.; Li, P. Effects of 5-HT6 receptor blockade in the neurochemical outcome of antidepressant treatment in the frontal cortex of the rat. J. Neural ., 2003, 110, 577-590 (Pubitemid 36683512)
110. Wesolowska, A. Study into a possible mechanism responsible for the antidepressant-like activity of the selective 5-HT6 receptor antagonist SB-399885 in rats. Pharmacol. Rep., 2007, 59, 664-671 (Pubitemid 351586557)
111. Wesolowska, A.; Nikiforuk, A.; Stachowicz, K. Anxiolytic-like and antidepressant-like effect produced by the selective 5-HT6 receptor antagonist SB-258585 after the intrahippocampal administration to rats. Behav. Pharmacol., 2007, 18, 439-446. (Pubitemid 47356370)
112. Svenningsson, P.; Tzavara, E.T.; Qi, H.; Carruthers, R.; Witkin, J.M.; Nomikons, G.G.; Greengard, P. Biochemical and behavioural evidence for antidepressant-like effects of 5-HT6 receptor stimulation. J. Neurosci., 2007, 27, 4201-4209 (Pubitemid 46597167)
113. Wesolowska, A.; Nikiforuk, A. The selective 5-HT6 receptor antagonists SB-399885 enchances anti-immobility action of antidepressants in rats. Eur. J. Pharacol., 2008, 582, 88-93
114. Hirano, K.; Piers, TM.; Searle, K.L.; Miller, N.D.; Rutter, A.R.; Chapman, P.F. Procognitive 5-HT6 antagonists in the rat forced swimming test: potential therapeutic utility in mood disorders associated with Alzheimer's disease. Life Sci., 2009, 84, 558-562
115. Carr, G.V.; Schechter, L.E.; Lucki, I. Antidepressant and anxiolytic effects of selective 5-HT(6) receptor agonists in rats. Psychopharmacology, 2010, Mar 9 [Epub ahead of print]
116. Meneses, A. Effect of the 5-HT6 receptor antagonist Ro 04-6790 on learning consolidation. Behav. Brain. Res., 2001, 118, 107-110 (Pubitemid 32037119)
117. Woolley, M.L.; Bentley, J.C.; Sleight, A.J.; Marsden, C.A.; Fone, K.C.F. A role for 5-HT6 receptors in retention of spatial learning in the Morris water maze. Neuropharmacology, 2001, 41, 210-219 (Pubitemid 32728092)
118. Rogers, D.C.; Hagan, J.J. 5-HT6 receptor antagonists enhance retention of a water maze task in the rat. Psychopharmacology, 2001, 158, 114-119 (Pubitemid 33020829)
119. Crile, R.; Falcone, J.; Bymaster, F.; Schaus, J.; Krushinski, J.; Giethlen, B.; Cohen, M.; McKinzie, D. Potency of 5-HT6 antagonists in radial arm maze acquisition is correlated with inhibition of ex vivo receptor binding in rat striatum. Neurosci. Abstr., 2002, 586, 11
120. Lindner, M.D.; Hodges, D.B.; Hogan, J.B.; Orie, A.F.; Corsa, J.A.; Barten, D.M.; Polson, C.; Robertson, J.; Guss, V.L.; Gillman, K.W.; Starrett, J.E. Jr.; Gribkoff, V.K. An assessment of the effects of serotonin 6 (5-HT6) receptor antagonists in rodent models of learning. J. Pharmacol. Exp. Ther., 2003, 307, 682-691 (Pubitemid 37310684)
121. Foley, A.G.; Murphy, K.J.; Hirst, W.D.; Gallagher, H.C.; Hagan, J.J.; Upton, N.; Walsh, F.S.; Regan, C.M. The 5-HT6 receptor antagonist SB-271046 reverses scopolamine-induced consolidation of a passive avoidance task and ameliorates spatial task deficits in aged rats. Neuropsychopharmacol., 2004, 29, 93-100 (Pubitemid 38068018)
122. Johnson, C.N.; Roland, A.; Upton, N. New symptomatic strategies in Alzheimer's disease. Drug Dis. Today, 2004, 1, 13-19 (Pubitemid 40208003)
123. King, M.V.; Sleight, A.J.; Wooley, M.L.; Topham, I.A.; Marsden, C.A.; Fone, K.C.F. 5-HT6 receptor antagonists reverse delay-dependent deficits in novel discrimination by enhancing consolidation -An effect sensitive to NMDA receptor antagonism. Neuropharmacology, 2004, 47, 195-204 (Pubitemid 38824643)
124. Liebnen, C.K.J.; Blokland, A.; Sik, A.; Sung, E.; van Nieuwenhuizen, P.; Schreober, R. The selective 5-HT6 receptor antagonists Ro4368554 restores memory performance in cholinergic and serotonergic models of memory deficiency in the rat. Neuropsychopharmacology, 2005, 30, 2169-2179 (Pubitemid 41643968)
125. Perez-Garcia, G.; Meneses, A. Oral administration of the 5-HT6 receptor antagonists SB-357134 and SB-399885 improves memory formation in an autoshaping learning task. Pharmacol. Biochem. Behav., 2005, 81, 673-682 (Pubitemid 40966815)
126. Hatcher, P.D.; Brown, V.J.; Tait, D.S.; Bate, S.; Overend, P.; Hagan, J.J.; Jones, D.N.C. 5-HT6 receptor antagonists improve performance in an attentional set shifting task in rats. Psychopharmacol., 2005, 181, 253-259 (Pubitemid 41492195)
127. Hirst, W.D.; Stean, T.O.; Rogers, D.C.; Sunter, D.; Pugh, P.; Moss, S.F.; Bromidge, S.M.; Riley, G.; Smith, D.R.; Bartlett, S.; Heidbreder, C.A.; Atkins, A.R.; Lacroiux, L.P.; Dawson, L.A.; Foley, A.G.; Regan, C.M.; Upton, N. SB-399885 is a potent, selective 5-HT6 receptor antagonist with cognitive enhancing properties in aged rat water maze and novel recognition models. Eur. J. Pharmacol., 2006, 553, 109-119 (Pubitemid 44779592)
128. Meneses, A.; Manuel-Apolinar, L.; Castillo, C.; Castillo, E. Memory consolidation and amnesia modify 5-HT6 receptors expression in rat brain: an autoradiographic study. Behav. Brain Res., 2007, 178, 53-61
129. Schreiber, R.; Vivian, J.; Hedley, L.; Szcepanski, K.; Secchi, R.L.; Zuzow, M.; van Laarhoven, S.; Moreau, J-L.; Martin, J.R.; Sik, A.; Blokland, A. Effects of the novel 5-HT6 receptor antagonist Ro4368554 in rat models for cognition and sensorimotor gating. Eur. Neuropsychopharmacol., 2007, 17, 277-288 (Pubitemid 46135932)
130. Mitchell, E.S.; Sexton, T.; Neumaier, J.F. Increased expression of 5-HT6 receptors in the rat dorsomedial striatum impairs instrumental learning. Neuropsychopharmacology, 2007, 32, 1520-1530 (Pubitemid 46920161)
131. Foley, A.G.; Hirst, W.D.; Gallagher, H.C.; Barry, C.; Hagan, J.J.; Upton, N.; Walsh, F.S.; Hunter, A.J.; Regan, C.M. The selective 5-HT6 antagonists SB-271046 and SB-399885 potentiate NCAM PSA immunolabeling of dentate granule cells, but not neurogenesis, in the hippocampal formation of mature Wistar rats. Neuropharmacol ., 2008,54, 1166-1174
132. Mitchell, E.S., Neumaier, J.F. 5-HT6 receptor antagonist of emotional learning and prepulse inhibition deficits induced by apomorphine or scopolamine. Pharmacol. Biochem. Behav., 2008, 88, 291-298 (Pubitemid 350116256)
133. Loiseau, F.; Dekeyne, A.; Millan, M.J. Pro-cognitive effects of 5-HT6 receptor antagonists in the social recognition procedure in rats: implication of the frontal cortex. Psychopharmacology, 2008, 196, 93-104
134. Marcos, B.; Chuang, T.T.; Ramirez, M.J. Effects of 5-HT6 receptor antagonism and cholinesterase inhibition in models of cognitive impairment in the rat. Brit. J. Pharmacol., 2008b, 155, 434-440
135. Fone, K.C.F. An update on the role of the 5-hydroxytryptamine6 receptor in cognitive function. Neuropharmacol., 2008, 55, 1015-1022
136. King, M.V.; Marsden, C.A.; Fone, K.C.F. A role for the 5-HT1A, 5-HT4 and 5-HT6 receptors in learning and memory. Trends Pharmacol. Sci., 2008, 29, 482-492
137. Da Silva Costa, V.; Duchatelle, P.; Boulouard, M.; Dauphin, F. selective 5-HT6 receptor blockade improves spatial recognition memory and reverses age-related deficits in spatial memory in the mouse. Neuropsychopharma col., 2009, 34, 488-500
138. King, M.V.; Spicer, C.H.; Sleight, A.J.; Marsden, C.A.; Fone, K.C.F. Impact of regional 5-HT depletion on the cognitive enhancing effects of a typical 5-HT6 receptor antagonist, Ro04-6790, in the novel object discrimination task. Psychopharmacology, 2009, 202, 111-122
139. Liu, K.G.; Robichaud, A.J. 5-HT6 antagonists as potential treatment for cognitive dysfunction. Drug Dev. Res., 2010, 70, 145-168
140. Burnham, K.E.; Baxter, M.G.; Bainton, J.; Southam, E.; Dawson, L.A.; Sharp, T.; Bannerman, D.M. The 5-HT6 receptor agonist WAY181187 enhances extradimensional set-shifting in the rat. Brit. J. Pharmacol., 2007, 5 (2), 27P
141. Kendall, I.; Slotten, H.A.; Codony, X.; Burgueno, J.; Pauwels, P.J.; Vela, J.M.; Fone, K.C.F. E-6801, a 5-HT6 receptor agonist, improves recognition memory by combined modulation of cholinergic and glutamatergic neurotransmission in the rat. Psychopharmacology, 2010, Pub ahead 20 April
142. Shacham, S.; Heal, D.J.; Cheetham, S.C.; Jackson, H.C.; Melendez, R.; Rutkowski, J.V.; Orback, P.; Gannon, K.S. PRX-07034, a potent and selective 5-HT6 receptor antagonist, reduces food intake and body weight in dietary-induced obese (DIO) rats. Soc. Neurosci. Abs., 2007, 62.10
143. Frassetto, A.; Zhang, J.; Lao, J.Z.; White, A.; Metzeger, J.M.; Fong, T.M.; Chen, R.Z. Reduced sensitivity to diet-induced obesity in mice carrying a mutant 5-HT6 receptor. Brain Res., 2008, 1236, 140-144
144. Heal, D.J.; Smith, S.L.; Fisas, A.; Codony, X.; Buschmann, H. Selective 5-HT6 receptor ligands: progress in the development of a novel pharmacological approach to the treatment of obesity and related metabolic disorders. Pharmacol. Ther., 2008, 117, 207-231.
145. Garfield, A.S.; Heisler, L.K. Pharmacological targeting of the serotonergic system for the treatment of obesity. J. Physiol., 2009, 598.1, 49-60
146. Fisas, A.; Codony, X.; Romero, G.; Diordal, A.; Giraldo, J.; Mercé, R.; Holenz, J.; Heal, D.; Buschmann, H.; Pauwels, P.J. Chronic 5-HT6 receptor modulation by E-6837 induces hypophagia and sustained weight loss in dietinduced obese rats. Brit. J. Pharmacol., 2006, 148, 973-983 (Pubitemid 44543615)
147. Glatt, C.E.; Snowman, A.M.; Sibley, D.R.; Snyder, S.H. Clozapine: selective labelling of sites resembling 5HT6 serotonin receptors may reflect psychoactive profile. Mol. Med., 1995, 1,1076-1551
148. Frederick, J.A.; Meador-Woodruff , J.HEffect of clozapine and haloperidol on 5-HT6 receptor mRNA levels in rat brain. Schiz. Res., 2010, 38, 7-12
149. Healy, D.J.; Meador-Woodruff , J.H. Ionotropic glutamate receptor modulation of 5-HT6 and 5-HT7 mRNA expression in rat brain. Neuropsychopharmacology, 1999, 21, 341-351 (Pubitemid 29333072)
150. East, S.Z.; Burnet, P.W.J.; Leslie, R.A.; Roberts, J.C.; Harrison, P.J. 5-HT6 receptor binding sites in schizophrenia and following antipsychotic drug administration: autoradiographic studies with [125I]SB-258585. Synapse, 2002, 45, 191-199 (Pubitemid 34827362)
151. Pouzet, B.; Didriksen, M.; Arnt, J. Effects of the 5-HT6 receptor antagonist, SB-271046, in animal models for schizophrenia. Pharmacol. Biochem. Behav., 2002, 71, 635-643 (Pubitemid 34219214)
152. Leng, A.; Ouagazzal, A.; Feldon, J.; Higgins, G.A. Effect of the 5-HT6 receptor antagonists Ro 04-6790 and Ro 65-7199 on latent inhibition and prepulse inhibition in the rat: comparison to clozapine. Pharmacol. Biochem. Behav., 2003, 75, 281-288 (Pubitemid 36859812)
153. Li, Z.; Huang, M.; Prus, A.J.; Dai, J.; Meltzer, H.Y. 5-HT6 receptor antagonist SB-399885 potentiates haloperidol and risperidone-induced dopamine efflux in the medial prefrontal cortex or hippocampus. Brain Res., 2007, 1134, 70-78 (Pubitemid 46135533)
154. Rodefer, J.S.; Nguyen, T.N.; Karlsson, J-J.; Arnt, J. Reversal of subchronic PCP-induced deficits in attentional set shifting in rats by sertindole and a 5-HT6 receptor antagonist: comparison among antipsychotics. Neuropsychopharmacol., 2008, 33, 2657-2666
155. Hedo, G.; Lopez-Garcia, J.A. 5-HT1B but not 5-HT6 or 5-HT7 receptors mediate depression of spinal nociceptive reflexes in vitro. Brit. J. Pharmacol., 2002, 135, 935-942 (Pubitemid 34214452)
156. Castaneda-Corral, G.; Rocha-Gonzales, H.I.; Araiza-Saldana, C.I.; Ambriz-Tututi, M.; Vidal-Cantú, G.C.; Granados-Soto, V. Role of peripheral and spinal 5-HT6 receptors according to the rat formalin test. Neurosci., 2009, 162, 444-452
157. Kindlundh, A.M.S.; Svenningsson, P.; Schioth, H.B. Quantitative mapping shows that serotonin rather than dopamine receptor mRNA expressions are affected by intermittent administration of MDMA in rat brain. Neuropharmacology, 2006, 51, 838-847 (Pubitemid 44286936)
158. Ferguson, S.M.; Mitchell, E.S.; Neumaier, J.F. Increased expression of 5-HT6 receptors in the nucleus accumbens blocks the rewarding but not psychomotor activating properties of cocaine. Biol. Psychiat., 2007, 63, 207-213 (Pubitemid 350299315)
159. Pitsikas, N.; Zisopoulou, S.; Pappas, I.; Sakellaridis, N. The selective 5-HT(6) receptor antagonist Ro 04-6790 attenuates psychotomimetic effects of the NMDA receptor anatagonist MK-801. Behav. Brain Res., 2008, 188, 304-309
160. Di Chiara, G.; Valentini, V.; Fenu, S.; De Luca, M.A.; Borsini, F. Reinforcing, rewarding and dopamine-stimulant properties of the 5-HT6 receptor agonist ST1936: the first member of a new class of psychostimulants? Behav. Pharmacol., 2009, 20, S9
161. Van Gaalen, M.M.; Schetters, D.; Schoffelmeer, A.N.; De Vries, T.J. 5-HT6 antagonism attenuates cue-induced relapse to cocaine seeking without affecting cocaine reinforcement. Int. J. Neuropsychopharmacology, 2010, Apr 29: 1-5 [Epub ahead of print]
162. Morairy, S.R.; Hedley, L.; Flores, J.; Martin, R.; Kilduff, T.S. Selective 5-HT2A and 5-HT6 receptor antagonists promote sleep in rats. Sleep, 2008, 31, 34-44
163. Routledge, C.; Bromidge, S.M.; Moss, S.F.; Price, G.W.; Hirst, W.; Newmann, H.; Riley, G.; Gager, T.; Stean, T.; Upton, U.; Clarke, S.E.; Brown, A.M.; Middlemiss, D.N. Characterization of SB-271046: a potent, selective and orally active 5-HT6 receptor antagonist. Brit. J. Pharmacol., 2000, 130, 1606-1612 (Pubitemid 30611938)
164. Freitas, R.L.; dos Reis Ferreira, C.M.; Castiblanco Urbina, A.M.; Marino, A.U.; Carvalho, A.D.; Butera, G.; de Oliveira, A.M.; Coimbra, N.C. 5-HT1A/1B, 5-HT6 and 5-HT7 serotonergic receptor recruitment in tonic-clonic seizure-induced antinociception: role of dorsal raphe nucleus. Exp. Neurol., 2009, 217,16-24
165. Azenha, D.; Alves, M.; Matos, R.; Fonte Santa, J.; Silva, B.; Cordeiro, C.; Nuno Viera, D.; Ambrosio, A.M. Male specific association between the 5-HTR6 gene 267C/T SNP and suicide in the Portuguese population. Neurosci. Lett ., 2009, 466, 128-130
166. Ham, B-J.; Kim, Y-H.; Choi, M-J.; Cha, J-H.; Choi, Y-K.; Lee, M-S. Serotonergic genes and personality traits in the Korean population. Neurosci. Lett., 2004, 354, 2-5 (Pubitemid 38041086)
167. Lane, H-L.; Liu, Y-L.; Huang, C-L.; Hsieh, C-L.; Chang, Y-L.; Chang, L.; Chang, Y-C.; Chang, W-H. Prefrontal executive function and D1, D3, 5-HT2A and 5-HT6 receptor gene variations in healthy adults. J. Psychiatry Neurosci., 2008, 33, 47-53 (Pubitemid 351252496)
168. Messina, D.; Annesi, G.; Serra, P.; Nicoletti, G.; Pasqua, A.; Annesi, F.; Tomaino, C.; Ciró-Candiano, IC.; Carrideo, S.; Caracciolo, M.; Spadaflora, P.; Zappia, M.; Savettieri, G.; Quattrone, A. Association of the 5-HT6 receptor gene polymorphism C267T with Parkinson's disease. Neurology, 2002, 58, 828-829 (Pubitemid 34211570)
169. Lee, S-H.; Lee, K-J.; Lee, H-J.; Ham, B-J.; Ryu, S-H.; Lee, M-S. association between the 5-HT6 receptor C267T polymorphism and response to antidepressant treatment in major depressive disorder. Psychiatry Clin. Neurosci., 2005, 59, 140-145 (Pubitemid 40524947)
170. Lorke, D.E.; Lu, G.; Cho, E.; Yew, D.T. Serotonin 5-HT2A and 5-HT6 receptors in the prefrontal cortex of Alzheimer and normal aging patients. BMC Neurosci., 2006, 7, 36-43
171. Tsai, S.J.; Liu, H.C.; Liu, T.Y.; Wang ,Y.C.; Hong, C.J. Association analysis of the 5-HT6 receptor polymorphism C267T in Alzheimer's disease. Neurosci. Lett., 1999, 276,138-139
172. Orlacchio, A.; Kawarai, T.; Paciotti, E.; Stefani, A.; Orlacchio, A.; Sorbi, S.; St George-Hyslop, P.H.; Bernardi, G. Association study of the 5-hydroxytryptamine6 receptor gene in Alzheimer's disease. Neurosci. Lett., 2002, 325, 13-16 (Pubitemid 34521969)
173. Kan, R.; Wang, B.; Zhang, C.; Yang, Z.; Ji, S.; Lu, Z.; Zhen, C.; Jin, F.; Wang, Li. Association of the HTR6 polymorphism C267T with age-onset Alzheimer's disease in Chinese. Neurosci. Lett., 2004, 372, 27-29 (Pubitemid 39505222)
174. Shinkai, T.; Ohmori, O.; Kojima, H.; Terao, T.; Suzuki, T.; Abe, K. Association study of the 5-HT6 receptor gene in schizophrenia. Am. J. Med. Genet., 1999, 88, 120-122 (Pubitemid 29156446)
175. Vogt, I.R.; Shimron-Abarbanell, D.; Newidt, H.; Erdmann, J.; Cichon, S.; Schulze, T.G.; Mueller, D.L.; Maier, W.; Albus, M.; Bormann-Hassenbach, M.; Knapp, M.; Rietschel, M.; Propping, P.; Nothen, M.M. Investigation of the human serotonin 6 [5-HT6] receptor gene in bipolar affective disorder and schizophrenia. Am. J. Med. Genet., 2000, 96, 217-221 (Pubitemid 30180865)
176. Masellis, M.; Basile, V.S.; Meltzer, H.Y.; Lieberman, J.A.; Sevy, S.; Goldman, D.A.; Hamblin, M.W.; Macciardi, F.M.; Kennedy, J.L. Lack of association between the T-C 267 serotonin 5-HT6 receptor gene (HTR6) polymorphism and prediction of response to clozapine in schizophrenia. Schizophr. Res., 2001, 15, 47, 49-58 (Pubitemid 32121770)
177. Ohmori, O.; Shinkai, T.; Hori, H.; Nakamura, J. Novel polymorphism in the 5'-upstream region of the human 5-HT6 receptor gene and schizophrenia. Neurosci. Lett., 2001, 310, 17-20 (Pubitemid 32778474)
178. Fukuo, Y.; Kishi, T.; Yoshimura, R.; Kitajima, T.; Okochi, T.; Yamanouchi, Y.; Kinoshita, Y.; Kawashima, K.; Naitoh, H.; Umene-Nakano, W.; Inada, T.; Kunugi, H.; Kato, T.; Yoshikawa, T.; Ujike, H.; Nakamura, J.; Ozaki, N.; Iwata, N. Serotonin 6 receptor gene and mood disorders: Case-control study and meta-Analysis. Neurosci. Res., 2010, Apr 13. [Epub ahead of print]
179. Max, S.I.; Monsma, F.J.; Sibley, D.R. Agonist-induced desensitization of 5-HT6 serotonin receptor-coupled adenylyl cyclase in stably transfected HEK-293 cells. J. Serotonin. Res., 1995, 2, 101-116
180. De Foubert, G.; O'Neill, M.J.; Zetterstrom, T.S. Acute onset by 5-HT6 receptor-Activation on rat brain-derived neurotrophic factor and activity-regulated cytoskeletal-Associated protein mRNA expression. Neuroscience, 2007, 147, 778-785 (Pubitemid 46990655)
181. Pena-Rangel, M.T.; Mercado, R.; Hernandez-Rodriguez, J. Regulation of glial Na+/K+-ATPase by serotonin: identification of participating receptors. Neurochem. Res., 1999, 24, 643-649 (Pubitemid 29218105)